Salt Lake City, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rob Hitchcock has been named as president and chief executive officer for #" Rob Hitchcock Rob Hitchcock, President and CEO, SelectHealth
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide 8-10-2024, 13:35